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Abstract 
Introduction Economic evaluations are used in health care to help decision-makers allocate their 
resources. The objective of this study is to evaluate the cost-effectiveness of mechanical chest 
compressions compared to manual chest compressions. This is done in a Swedish setting and for out-
of-hospital cardiac arrests (OHCA) using results from a large randomized controlled trial, the LINC 
study1.  
Methods Mechanical CPR has been seen to improve neurological outcomes determined by the 
Cerebral Performance Category, and these results are used in a cost estimation to evaluate the 
effectiveness of treatment. This study argues costs and effects as far as possible to give meaning to 
this measurement despite its limitations. The analysis is made with a Swedish decision-makers 
purchasers’ perspective, as the societal perspective is considered in the discussion. A representative 
example was used to find the results and describes a case where 154 out-of-hospital cardiac arrest 
patients are annual possible treatments for 12 mechanical devices. Costs are calculated for the 
number of mechanical devices needed to deal with these patients along with treatment costs and 
additional hospital stay costs for mechanical treated patients. Effects of treatment are taken from 
the LINC study and a study by Phelps, Dumas, Maynard, Silver, & Rea (2013) and were translated into 
quality-adjusted life years (QALY). This is done with a focus group (clinical active medical doctors and 
nurses) that together answer a standardized instrument, EQ-5D, and in this way the paper obtain 
QALY-weights for each CPC-score. 
Results The cost-effectiveness of mechanical CPR is presented from a short-term perspective 
(patients’ gains in QALY during the first 6 months) as well as a longer-term perspective (patients’ gain 
in QALY over 8 years). As time prolongs the incremental cost-effectiveness ratio results show that 
costs per QALY gained range from “high” 508,291 SEK (6 months) to ”low” 50,508 SEK (8 years). 
Mechanical CPR shows to save 0.046 QALYs per OHCA patient over an 8-year period. The sensitivity 
analyses indicate that results do vary a lot with yearly number of treatments expected per device and 
the applied timeframe for effect calculation. 
Conclusion The paper believes to have given a transparent overview of a representative example 
facing decision-makers in this area. Giving them with the possibility to look at the value of 
mechanical CPR in a longer timeframe and not just in the short run with survival as only outcome. It 
concludes that if decision-makers are willing to live with the uncertainties discussed and argued in 
this paper, then mechanical devices are available at low costs per QALY gained for the patients 
treated. This is when each device is expected to deal with 12.83 yearly out-of-hospital cardiac arrests 
cases.  
 
 
Key words: Cardiopulmonary Resuscitation, Cerebral Performance Category, Cost-effectiveness, EQ-
5D, Delphi Method, And Out-of-hospital Cardiac Arrest  
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1. Introduction 
 
1.1 Background 
Economics is the science of scarcity. Health economics displays a desire to maximize the value of the 
budget by ensuring not just clinical effectiveness, but also the cost-effectiveness of health care 
provision. Since 1997, cost-effectiveness has become a key criterion in Sweden when deciding which 
new health care intervention that should be publicly funded. The Swedish healthcare law states that 
there must be a reasonable relation between costs and effects, in terms of improved health and 
increased quality of life2. Unless the cost-effectiveness also was highlighted the risk would be that 
very urgent illnesses were treated to such high costs that resources remaining to treat others in need 
were not there in time. Decision-makers and purchasers within the ambulance organization within 
the Swedish health care system is mainly government-funded and has the society in its perspective. 
A common cause of death in the western world is cardiovascular diseases. Despite a decreasing trend 
over the past decades, cardiovascular diseases were still responsible for 45 percent of all deaths in 
Sweden in year 2012. These 34,949 persons died from cardiovascular diseases of which about 10,000 
were classified as cardiac arrests. Of 5,000 cases of Out-of-Hospital Cardiac Arrests (OHCA) each year 
in Sweden, to date only 10 percent can be expected to survive. Figure 1 shows the number of 
patients with survival 6 months after cardiac arrest, by age group with data from the LUCAS In 
Cardiac Arrest (LINC)-study3. Those expected to be able to survive to 6 months after the arrest are in 
the age groups below 80 years old.  
Early and effective treatment is of vital importance to increase chances of survival4. Several factors 
are important to increase survival rates after OHCA such as; recognition of state, effective 
Cardiopulmonary Resuscitation (CPR), defibrillation, post-resuscitation care to achieving Return of 
Spontaneous Circulation (ROSC)5. CPR is physically demanding and variations in provision of good 
quality CPR according to guideline standards have been observed6. The effectiveness of manual CPR 
is largely dependent on the skill and endurance of the rescuer7. Success might depend on the ability 
to compress deep enough and not having a too long hands-off interval during the resuscitation 
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attempt8. Two mechanical chest compressors, called AutoPulse and LUCAS, have been shown to 
improve ROSC in small studies9  and have been developed to improve the quality of CPR.  
A large randomized controlled trial, the LINC-study10, had the objective to determine whether 
administering mechanical CPR combined with defibrillation compared with manual CPR, would 
improve survival. Results showed no change in 4-hour survival in OHCA patients between the two 
treatments. The LINC-study also involved an outcome of the well-known neurological outcome 
measure called Cerebral Performance Category (CPC) Score. This paper aims to use the results from 
the LINC-study as a foundation for the implementation of a cost-effectiveness analysis on mechanical 
CPR vs. manual CPR.  
Up to this date this study is the first to exploit this reasoning. Nonetheless two ongoing studies have 
been identified to investigate mortality combined with QALY-calculation in England and Finland11. 
Being able to find a better way to deal with OHCA and identify cost-effective technologies for OHCA 
are vital for optimizing the use of healthcare spending in Sweden and elsewhere. 
 
1.2 Purpose of the study 
The purpose of this study is to evaluate the long-term incremental cost-effectiveness of mechanical 
CPR and simultaneous defibrillation vs. conventional manual CPR for patients with OHCA, in Sweden. 
This study wants to perform a cost-effectiveness analysis by evaluating CPC as an outcome 
measurement in a cost estimation. To demonstrate this, the study needs to calculate the value of 
treatment by mapping CPC-scores to corresponding EQ-5D dimensions and use these QALY-weights 
to describe the outcome of mechanical CPR and manual CPR during the 6 months follow up in the 
LINC-study. To obtain a longer perspective this paper models the expected long-term survival based 
on CPC -scores from the LINC-study data and other published sources. 
Together these aims will provide estimates of a long-term value of alternative methods for providing 
good quality CPR in Sweden. They will also give insight of CPC as a measurement effect within a cost 
estimation. 
 
1.3 Methods 
In order to achieve the aim of this paper, a cost-effectiveness analysis was performed on results from 
the LINC-study. These results appeared from a trial where a mechanical device (LUCAS), with 
simultaneous defibrillation was being compared to conventional manual CPR, both in an OHCA 
environment. To get an understanding of what happens after 6 months literature searches was made 
using PubMed database. The only study to truly deal with long-term prognosis for different CPC-
scores following OHCA was one by Phelps et al. (2013). In an American setting this paper gave 
additional insight for this papers’ calculations. This paper extracts the survival rates from Phelps 
study by up to 8 years, which is the same as the economic lifetime of a LUCAS device. 
This paper will use a representative example based on Skånes Universitets Sjukhus, Malmö and 
perform a cost-effectiveness analysis more thoroughly described in chapter 4. The costs will be based 
on a mechanical device called LUCAS. The effects in quality-adjusted life years (QALY) were chosen to 
not only consider lives saved, but also the quality of life in those years.  
The decision-makers in Sweden have stated that a societal view should be applied when dealing with 
direct and indirect costs12. This however was found to be too problematic for the CPC-scale and 
therefore only the direct costs are included in the cost estimation and the indirect costs are 
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discussed in chapter 6. To deal with the effects this paper estimated different QALYs for patients with 
different CPC-scores using the Delphi Method with a focus group of the people who assessed CPC-
scores in the patients included in the LINC-study.  
 
1.4 Outline/Disposition 
From here on chapter 2 will present the subject of health economics evaluation and why it is needed 
and used within Swedish health care. Chapter 3 will introduce the reader to the phenomenon of 
sudden cardiac arrest and how its outcomes are measured. It will also introduce the possible effect 
difference between mechanical CPR and manual CPR. As it will expand the concept of Cerebral 
Performance Category-score as a measurement used to evaluate patient outcome after a cardiac 
arrest. This outcome will be the foundation for this papers’ cost estimation. In chapter 4, the paper 
will explain the method and material used in this study, how the costs and effects were measured 
and evaluated. The results of the way of method will be presented in chapter 5 along with sensitivity 
analysis as results cannot be compared to previous research. These results are then discussed in 
chapter 6 along with covering other areas of interest in the field of the value of CPR.  
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2. Health economic evaluations 
The purpose of this chapter is to provide the reader with knowledge of why and how a cost-
effectiveness analysis (CEA) is constructed. It will also give insight into the common forms of 
economic evaluations and propose a way to calculate quality-adjusted life years (QALY). 
 
2.1 Analysis Frame 
Healthcare is produced through allocation with scarce resources, which requires priority setting. 
With the constant discussions on lack of resources within the healthcare sector, health economic 
evaluation has lately gained a growing influence in prioritizing decisions. But on whose conflicting 
objectives should we base the analysis?  
There are three different perspectives when making an economic evaluation. Consistent with 
economic theory there is the welfarist perspective, which gives the same results as a free market 
would. If instead trying to optimize the resources of the health care sector budget one could use the 
extrawelfarist perspective by comparing costs with health gained. At last a broader societal 
perspective includes a wider range of consequences in costs and health effects and it is called the 
decision-makers perspective. The analysis in this paper has a Swedish outlook and will try to apply 
the perspective of the decision-maker, aiming to optimize the effects, compared to costs, for society 
as a whole13. 
Swedish citizen get health care based on their need and not their ability to pay. Based on economic 
theory one could argue that a public intervention is motivated when viewing health as a public good. 
However health care is a private good with externalities affecting the others in the society. An 
illustrative example of the positive externalities within health care, are those gains made from a 
vaccination program. When one citizen gets a vaccine-treatment this will lower the risk of disease for 
all other citizens. This example gives support to a public intervention, but does not answer the 
question of how much of the resources that should be put in use. New medical interventions emerge 
by the day. The population in Sweden is ageing, leading to a smaller health care budget. As stated 
above a health economic evaluation is of worth. Economic evaluation is defined by Drummond et al. 
(2005) as “the comparative analysis of alternative courses of action in terms of both their costs and 
consequences”. Applicable to all economic evaluation its aim is to identify, measure and compare 
different interventions. Within health economics it is the costs and effects of different alternatives 
for prevention, diagnosis, treatment and rehabilitation of diseases that are subject to evaluation14. 
Decision-makers are not only concerned about the costs, but understandably also the result.  
In order to create an understanding of the different approaches to health economic problem solving, 
different methods of analysis will now be discussed. 
 
2.2 Methods of analysis for health economic evaluations 
Health economic evaluations consist of four different analysis methods: a cost-minimizing analysis, 
cost-effectiveness analysis (CEA), cost-utility analysis and cost-benefit analysis. It should be noted 
that some authors do not distinguish between CEA and cost-utility analysis. Instead they are writing 
and treating cost-utility analysis as a special case of CEA15. Further on in this discussion the reader 
should remember that despite their names all forms of analysis has the same purpose, to determine 
cost-effectiveness of an intervention. All four are based on identifying and evaluating the costs. But 
they differ some when it comes to the measuring and assessment of the effects16. 
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2.2.1 Costs and costs identification 
Costs can be of different types and should in health economics be valued as the opportunity cost. 
Meaning the value of the effects that should have occurred if the best available alternative would 
have been used. The total costs of a treatment will differ depending on the perspective used, for 
example: patient, hospital, government or society17. As stated above this paper will target the 
decision-makers in Sweden, The Dental and Pharmaceutical Benefits Agency18. Meaning the aim is to 
use a societal perspective dealing with all related costs, both direct and indirect19. 
Related costs are those associated with the treatment. Unrelated costs are those not directly linked 
to the specific illness or cause. Direct costs correspond to healthcare resources that the treatment 
involves, for example; costs for inpatient (e.g. bed price/day* number of days) and outpatient care 
(ex. physician visits), nursing care, and drug costs. Indirect costs relate to mainly production losses 
due to sick days, reduced employment or premature death. If in advance a specific cost is unrelated 
and known not to affect the result, it can preferably be excluded from the analysis. Most often these 
are small costs with marginal impact on the cost analysis. It would also be useful to eliminate costs 
shared by all treatments being compared, as they leave no impact on the results. For example the 
indirect costs could be assumed to differ between treatments if a person is treated differently 
depending on their CPC-value.  
Different health economic evaluations use different approaches on how to estimate the indirect 
costs. The human capital approach estimates productivity by using gross earnings, containing 
employment costs and social fees. An alternative way is the friction cost approach that estimates 
productivity changes depending on the time that patients need to restore initial productivity level, 
which will differ between different types of work20. However this paper will have a hard time dealing 
with these indirect costs, but instead debate possible improvements to the area in in chapter 6. 
Once the costs are identified they have to be measured and evaluated. The estimation is not always 
obvious as healthcare production equipment often is used for several different treatments, therefore 
costs should be shared in proportion. It should also be noted that the final outcome may vary with 
different time aspects and one should avoid manipulating the usage of time periods that might 
benefit one treatment over the other21. When knowing what costs should be treated, the four 
different analysis methods can be clarified. 
 
2.2.2 Cost-minimizing, cost-benefit, cost-effectiveness and cost-
utility analysis  
An overview of the four types of analysis is presented in Table 1 from Kobelt (2002). Here, one can 
learn that the simplest form of a health economic evaluation is a cost-minimizing analysis. While 
evaluating two or more alternatives this kind of analysis assumes no difference between treatments, 
meaning that the treatment with lowest costs is always preferred.  
A cost-benefit analysis will try to price all consequences of the intervention into monetary values. 
This can be performed with three different approaches; human capital, revealed preferences and 
contingent valuation, all with different pros and cons. One example is a willingness-to-pay study, 
which is a basic contingent valuation method that has its difficulties in creating hypothetical 
situations for respondents. With this tool the author will estimate respondents’ monetary beliefs, 
understanding that any miscommunication will cause biasness in the study results. If possible, a CEA 
or cost-utility analyses are more preferred when performing an economic evaluation between 
treatments within the health sector22. 
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TABLE 1 METHODS OF ECONOMIC EVALUATION 
Method of analysis Effect measure 
Cost-minimizing analysis  Effect is assumed to not differ between treatments. 
Cost-benefit analysis Effect is measured in monetary terms. For example through willingness 
to pay. 
Cost-effectiveness analysis (CEA) A specific effect measure is used. For example life years saved. 
Cost-utility analysis An effect measure that combines survival with life-quality. Often 
quality-adjusted life-years (QALYs) 
 
 
A CEA measures effects in single one-dimensional outcomes, for example; the number of painless 
days, units of treated patients or in gained life-years. Cost-effectiveness models are used to assess 
the relative benefits of a given intervention using patient outcomes and the costs incurred in 
achieving those outcomes. The calculation of the additional cost per additional unit gain of benefit is 
known as the incremental analysis and results are presented as incremental cost-effectiveness ratio 
(ICER). Equation 1 is a calculation example where A and B stands for the different treatments. This 
allows the ratio between the difference in costs and effects between the two treatments to be 
calculated.  
EQUATION 1 INCREMENTAL COST-EFFECTIVENESS RATIO (ICER)  
      
            
               
 
 
For example B could be the new treatment (mechanical CPR) and A could be the old treatment 
(manual CPR). To obtain a result on the cost-effectiveness one needs to know the costs differing 
between the treatments and have an effect to measure. As seen in Table 1 one could for example 
measure life-years saved. Cost-utility analysis is said to take CEA one-step further by combining 
effects into a one-dimensional outcome. This outcome is either disease-specific, such as cases 
detected or avoided, or more general in the form of life-years gained. Within healthcare a relevant 
measure of effect is the quality-adjusted life year (QALY) gained and it was also chosen as the 
outcome in this paper. It will be further explained in the chapter below. 
 
2.3 Quality-adjusted life years 
A QALY is a health indicator of the combined effect of surviving and the life quality of those years. To 
be able to estimate a QALY, the time spent during a certain health condition is weighted by a certain 
value ranging on a scale from 1, representing perfect health, and the number 0, representing death. 
It should be noted that QALYs could be less than zero when the scenario presented is considered to 
be worse than death. Some methodological problems has been shown to this original approach and 
it is a standard within the area to set the low bar to zero, therefore this paper will call this the 
conservative approach23. A way to describe a QALY calculation is to present it with a figure. Figure 2 
shows sequences over time, that are associated with QALYs gained, from choosing treatment A 
instead of treatment B. It should be noted that the area could be split into gain in quality and the 
gain in quantity of life. These occur to the left and the right of the death of person 1. 
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FIGURE 2 QALY CALCULATION 
 
QALYs have to be calculated in some way and attempts for obtaining general guidelines, when 
calculating patients’ preferences for different treatments, have been made. Some standardized 
Health Related Quality of Life- instruments are the HUI, SF-6D and EQ-5D, which is most used.  
This study applies the well-known EuroQol Group (EQ-5D) survey by Dolan (1997) that describes the 
individuals’ health state by five dimensions; Mobility, Pain/Discomfort, Self-care, Anxiety/Depression 
and Usual activities. For the readers’ better understanding this explanation has been moved to 
chapter 4.4.1. 
 
2.4 Swedish national guidelines 
When results are presented in the ICER-ratio (Equation 1) the decision-makers need to make their 
decision regarding the new treatment. Figure 3 is called a cost-effectiveness plane and is an 
illustrated comparison between four possible outcomes of costs and effects. As for example 
mechanical CPR will be more costly than manual CPR (ending up on the north side). Then depending 
on whether it is less effective or more effective it will test the decision-maker. If it is more costly and 
less effective (northwest corner) it will be dominated by manual CPR and if it is more costly and more 
effective (northeast corner) it should be considered depending on its ICER-ratio. Most preferred for a 
new treatment is the notation of dominating another strategy, occurring when the new treatment is 
both more effective and cheaper. 
13 
 
FIGURE 3 COST-EFFECTIVENESS PLANE 
 
 
 
By using the concept of QALYs it is possible to compare treatment of different diseases24. CUA and 
CEA identify only the best alternatives in terms of cost per QALY gained. The Swedish National board 
of Health and Welfare25 has developed an assessment of costs in relation to effects presented in 
Table 2. This gives indications on what is cost-effective and which alternative that should be 
implemented when ending up in the northeast corner in Figure 3. It should be noted that these 
borderlines are only terms of reference and that the cost-effectiveness principle in Sweden should be 
applied so that the requirement for cost-effectiveness is higher for less serious medical conditions. 
This principle is called the needs and solidarity principle. A principle that stands above both these is 
the principle of human dignity standing for good health at equal terms for everyone26.  
 
TABLE 2 GROUPING OF COST PER QALY GAINED, DEVELOPED BY THE SWEDISH NATIONAL BOARD OF HEALTH 
AND WELFARE 
Cost in relation to 
gain in health 
Cost per QALY (SEK) alternatively gained life year 
Low < 100 000 SEK per QALY 
Moderate 100 000 - 500 000 SEK per QALY 
High 500 000 - 1 000 000 SEK per QALY 
Very High > 1 000 000 SEK per QALY 
Not gradable The action has no effect (there exists evidence of no 
effect) alternatively it cannot be evaluated. 
 
2.5 Discounting 
Discounting means a value counted backwards in time with respect to a given interest rate as a way 
to deal with future uncertainties. This is a problem stemming from “time preference”, which refers to 
not all costs and benefits occurring at the same time. For example human behavior such as drinking 
and smoking shows that people value current pleasure higher than future possibly damaging effects. 
An economic example is that people hire videos for home viewing instead of waiting an extra time 
period to get the same “effect” for a lower price. If not applying discounting this means that health 
effects today would be accounted for the same way as for those gained in 10 or 15 years27. Berggren, 
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& Andersson (2001) have gathered and showed formal and informal guidelines within health 
economics. Guidelines agree that some form of discounting needs to be applied. It is pointed out that 
depending on which perspective one chooses to adopt, different outcomes are possible. When 
discounting health improvements it makes future populations health benefits lesser valued. Equation 
2 shows how discounting is calculated and how we get the present value of future costs and effects. 
For example this study will use the same discount rates as The Swedish Dental and Pharmaceutical 
Benefits Agency recommends, namely 3 percent for both costs and effects and a sensitivity analysis 
ranging from 0-5 percent28. A common rule is to present the results both with and without 
discounting29. 
EQUATION 2 PRESENT VALUE CALCULATION 
    
  
      
 
Where: 
PV= Present Value 
FV= Future Value 
i= interest 
n= number of time periods 
 
In order to provide an appropriate background of the subjects discussed in this study, we will prior to 
the analysis review the recent research within the field. 
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3. Sudden cardiac arrest and Cardiopulmonary 
Resuscitation 
This chapter will further introduce the reader to the nature of sudden cardiac arrest and CPR and the 
potential advantages that mechanical CPR offers over manual CPR. This chapter also gives a brief 
overview of the classification and reporting in clinical findings. 
 
3.1 Medical background 
A large percentage of the people who die due to cardiac arrest die before arrival to the hospital in an 
Out-of-Hospital Cardiac Arrest (OHCA). For every minute that passes before help arrives, the 
patients’ body starts getting severe damage. This is caused by the lack of oxygen to the brain and 
other vital organs, resulting from the cardiac arrest. The risk of death increases by ten percent for 
each minute that treatment has not started and death is inevitable after about fifteen minutes. The 
probability of surviving an OHCA increases dramatically if ventilation and circulation artificially can be 
kept running while awaiting ambulance arrival. There is a simple method to accomplish this, CPR, 
which typically involves manually pressing on the chest to keep the circulation going30. CPR is 
performed to achieve Return of Spontaneous Circulation (ROSC), which means that the heart is 
beating by its own again. Achieving good quality CPR is physically demanding and variations in 
provision of CPR according to guideline standards have been observed31. The effectiveness of manual 
CPR is largely dependent on the skill and endurance of the rescuer32. Success depends on the ability 
to compress deep enough and not having too long hands-off interval33. As stated in chapter 1.1, two 
mechanical chest compressors have been developed, named AutoPulse and LUCAS. 
The two chest compression systems differ and as an example the LUCAS chest compression system is 
a battery-driven, piston-driven, lightweight (7.8kg), compact device designed to help improve 
outcomes of cardiac arrest patients and improve operations for the health care staff. LUCAS can 
consistently do 100 compressions per minute with a depth up to 5 cm, which is according to 
guidelines 34 . LUCAS can be deployed to patients within 20 seconds 35 . The Autopulse does 
circumferential compressions with a belt, weight 17 kg and compresses the chest with 80 
compressions per minute with a depth of 20% of the chest height36. 
Mechanical chest compressors aims to save lives of cardiac arrest patients and avoid neurological 
damage, which is achieved by a steady supply of oxygen to the heart (achieving ROSC) in combination 
with simultaneous defibrillation. For those patients who do survive to arrive to the hospital, there are 
advanced care resources for post-resuscitation care. 
The suspected causes of the cardiac arrests are presented for both the LINC-study and the Swedish 
Annual CPR registry in Table 3. These results imply that the LINC-study population is fairly well 
matched with the Swedish population as a whole. More on this in chapter 4.1.  
TABLE 3 SUSPECTED CAUSE OF CARDIAC ARREST 
Cause of arrest LINC study Swedish Annual CPR Registry 
Heart disease 71 % 66 % 
Pulmonary disease 6 % 6 % 
Respiratory arrest 5 % 2 % 
Intoxication 3 % 2 % 
Drowning 0 % 1 % 
Other 15 % 24 % 
Total 2,329 62,758 
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Sudden cardiac arrest can occur to anyone, but generally speaking, those who are at risk are divided 
into three groups. First those who are impossible to foresee as they show no diagnosis, no symptoms 
and have no relatives who has sustained cardiac arrest. Next the ones with symptoms such as chest 
pains, dizziness or unexplained fatigue. These people have perhaps not understood their symptoms 
as serious and the physician will have problem connecting them to a specific heart disease. Lastly the 
group where a diagnosis has been made and it is up to the physician to make an adequate risk-
assessment on what treatment to take37. This indicates that the possible gains within cardiac arrest 
might come from other areas that are not associated with mechanical CPR. 
One cannot foresee who will suffer a cardiac arrest, but it is still interesting to know that the number 
of cardiac arrest caused by heart disease increase by age. In Figure 4, from the Swedish national 
registry by Herlitz (2013) it is shown that the proportion of patients with a witness, surviving to one 
month, does decrease drastically by age. Giving us reasons to believe that the people who outlive a 
cardiac arrest are commonly younger. This means not that mechanical CPR aim to save a certain 
group of patients.  
FIGURE 4 PERCENTAGE CHANCE OF SURVIVAL TO 1-MONTH, IN OHCA CASES WITH A WITNESS 
 
 
But to what kind of life are the patients rescued to and how is this measured? The next section will 
deal with a measurement outcome used within the health care to determine brain capacity and 
future health state. 
 
3.2 Cerebral Performance Category  
A consensus statement regarding procedures for 
the classification and reporting of incidents and 
clinical findings, the so-called Utstein protocol has 
been published38.  They determine in what way 
and by what time one should report the forecasts 
and results in scientific studies. The protocol 
recommends using the evaluation of Cerebral 
Performance Category-score (CPC), see (Box 1)39. 
This should be carried out at discharge from 
hospital and at one year after the cardiac arrest. 
The Swedish national registry does treasure CPC at 
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BOX 1 CEREBRAL PERFORMANCE CATEGORY SCALE 
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hospital enrollment and discharge, when following up the outcome of OHCA patients 40. The LINC-
study for example lets nurses and physicians determine the CPC-score of patients at four times 
through time. After discharge from intensive care unit (ICU), discharge from hospital, 1 month after 
ROSC and 6 months after ROSC. 
CPC is used extensively due to simplicity, it is done to follow patient improvement over time, plan 
realistic rehabilitation operations and evaluate treatments41. It aims to assess domains of functioning 
after a cardiac arrest. For example, a CPC-score of 2 represents three domains of function: 
impairment (e.g. presence of hemiplegia, mental changes), level of activity performed (e.g. ability to 
dress independently) and level of participation (e.g. sufficient cerebral function to work part-time in 
a sheltered environment) 42 . However studies have shown that its validity as being directly 
transferable to a QALY-instrument after cardiac arrest is rather low43.  
Internationally as well as in Sweden CPC serves as a gold standard, functioning as a marker for how 
treatment should proceed44. Differences in CPC-outcome have been shown by Phelps et al. (2013) to 
have effects on expected future life-years, this is an area this paper will exploit45.  Phelps looks into 
the correlation between CPC and survival risk ratios, which is more thoroughly explained in chapter 
4.1. They make that CPC at discharge from hospital is a useful tool for programmatic evaluation and 
research.  
This chapter has informed the reader that CPC is used in clinical trials and it gives ideas to perform a 
numerical example, with CPC as a base for effects, on the cost-effectiveness of mechanical CPR 
compared to manual CPR.  
 
3.3 Previous Research 
As indicated above, mechanical CPR offers a potential advantage over manual CPR. Gates, Smith, 
Ong, Brace, & Perkins (2012) reviewed the literature on 322 studies comparing mechanical CPR, using 
the LUCAS device, with manual CPR. Table 4 from their study shows that the number of studies 
included in the analysis was fifteen, whereof three were on animals46. The meta-analysis covered 
studies with outcomes of survival and ROSC. Measures on ROSC were conducted in a pre-hospital 
setting for the human studies. Showing small but insignificant results favoring the mechanical LUCAS 
device. The three animal studies follow the same reasoning. Studies on survival have in common that 
they omitted important details of their methodology such as procedures for randomization and 
blinding leading to high risk of bias and their heterogeneity mean that results should be considered in 
caution.  
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TABLE 4 RESULTS FROM A META-ANALYSIS BY GATES ET AL. (2012) OF MECHANICAL CPR VS. MANUAL CPR 
 
 
 
As perceived in Table 4, evidence on important clinical outcomes of treatment are inconclusive up to 
this date. In studies where conclusions are stronger those studies are also severely limited by 
methodological weakness and poor reporting. For example only one of the human studies was a 
small-randomized controlled trial. A Swedish before & after abstract suggested that the introduction 
of LUCAS was associated with a greater number of resuscitation attempts, more patients being 
admitted to emergency departments, and an increase in survival up to 30 days47. 
To sum up this chapter the needs to clarify results with a high-quality trial was identified. One such 
large-scale randomized controlled trial of LUCAS, the LINC-study, has been published after Gates et 
al. (2012) meta-analysis. The LINC-study is the main reason that this study focuses on LUCAS as a 
representation for mechanical CPR when measuring the value of mechanical CPR and simultaneous 
defibrillation vs. conventional manual CPR in OHCA, in Sweden.  
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4. Material and method 
Presented in Figure 5 is a description of the study design and method used. This is included for the 
reader to easier follow the path that this papers’ cost estimation takes. In chapter 4.1 the main 
material for this analysis is presented and deals with CPC-scores from mechanical CPR and manual 
CPR in an OHCA setting. This could be associated to the mechanical CPR vs. manual CPR branch in the 
figure. Chapter 4.3 takes on the costs for a LUCAS device, as a yardstick for mechanical CPR, and 
explains this representative example more thoroughlyb. This is associated to the Pre-hospital branch 
in the figure. Lastly in chapter 4.4 the analysis uses a focus group from the LINC study to convert CPC-
scores and survival to QALYs calculating the effects with different approaches to QALY weights. This 
is the bottom branch in the tree in Figure 5. 
FIGURE 5 STUDY DESIGN OF THE REPRESENTATIVE EXAMPLE 
 
 
4.1 Material 
As stated, this study is based on the LINC-study: “Mechanical Chest Compressions and Simultaneous 
Defibrillation vs. Conventional Cardiopulmonary Resuscitation in Out-of-Hospital Cardiac Arrest” 
published by Rubertsson et al. (2013). The study was made between January 2008 and February 
2013, and performed its trial at six advanced life support emergency medical services, whereof four 
where in Sweden, one in the Netherlands and the last one in the United Kingdom. In which all results 
are assumed to be applied to a Swedish scenery. The protocol has been described in detail 
elsewhere48. The LINC-study concludes no improved 4-hour survival vs. manual CPR, according to 
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guidelines. However they also look at secondary outcomes such as neurological outcome CPC-scores, 
which are explained in chapter 3.2.  
The LINC-study presents the number and percentage of survivors divided into CPC-scores in their two 
groups L-CPR (LUCAS/mechanical) and M-CPR (manual). This can be seen in Appendix C, where the 
reader could imagine that using mechanical CPR instead of manual CPR will make the patient end up 
with a lower (better) CPC-score. Tracking the darkened bars in the appendix figure sees this. When 
evaluating the CPC-scores of the patients at discharge from intensive care unit (ICU), there exists a 
significant difference at the 5 percent level between the patient groups evaluated with a CPC-score 
of 1. At discharge from hospital this significance remains under the lower presumption. This allows 
room for exploring the possibility that using mechanical CPR could be more effective in terms of 
achieving a CPC-score of 1 compared to manual CPR. 
When conducting a CEA of a treatment one needs to decide on the appropriate timeframe. The basic 
rule is that the analysis should capture the relevant costs and effects that the treatment gives rise to. 
For chronic conditions, it is usually appropriate to apply the remainder of the patients' lives as a 
timeframe49. For cardiac arrest a long-term perspective is usually known to be 6-12 months50. Since 
the economic lifetime of a LUCAS device is 8 years this study states that this timeframe is suitable as 
a long-term perspective, more on this in chapter 4.3.  
Therefore this paper is also based on the work by Phelps et al. (2013) who sought to determine 
whether CPC was associated with long-term outcome following resuscitation from OHCA. With a 
retrospective American cohort investigation from January 1, 2001 and December 31, 2009 they use 
Kaplan-Meier curves to evaluate the association between CPC and long-term survival starting at 
hospital discharge. The program FindGraphc made it possible to subtract the change per month 
showed in Appendix D. The graph tells us that CPC-scores, going from 1 to 4 in falling order, are of 
effect when determining long-term survival starting from hospital discharge, in America. Their results 
show that more favorable CPC was associated with better long-term prognosis. For example, at 96 
months (8 years) survival was 66 % for CPC 1; 51 % for CPC 2; 31 % for CPC 3 and 17 % for CPC 4.  
 
4.2 Method and construction of representative example 
The LINC-study shows no significant effects regarding survival in patients treated with mechanical 
CPR. In this section the paper evaluate the way of method in the cost-effectiveness of mechanical 
CPR vs. manual CPR. This is done to explore if some sort of weight can be attached to the usage of 
mechanical CPR. As stated this paper is the first within this field. Also no studies have, up to our 
knowledge, evaluated the quality-of-life for patients who have undergone a mechanical treatment. 
Therefore this study will expand the usage of CPC as a measurement and perform a calculation 
example with a representative cohort as described in Figure 5. 
For this calculation example the results from the LINC-study will be used to create a 154 person 
hypothetical population for each treatment group. This is done to form create an example of how 
often the device is used each year. The size of the hypothetical cohort is chosen as a typical example 
of number of OHCA cases in SUS, Malmö catchment area in Sweden.  
According to data from Herlitz (2013) Swedish annual index, Malmö pre-hospital-region has 55 OHCA 
cases per 100,000 inhabitants. The Study Protocol for the LINC has been used to show that SUS, 
Malmö has 280,000 inhabitants and 12 LUCAS devices, as seen in Appendix B. (2.8 times 55) = 154 
                                                                
c
 Program can be downloaded at: http://www.findgraph.com/ 
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annual OHCA cases that will be possibly treated by 12 mechanical devices. This gives an average 
OHCA usage per mechanical device of approximately 12.83 OHCA cases per year. Meaning that each 
of the 12 devices will deal with 12.83 possible patients in an OHCA setting each year. Sensitivity 
analysis will also be made to see what happens to the cost-effectiveness if the hospital instead buys 
30 devices (5.13 OHCA treatments per device/year) or 8 devices (19.25 OHCA treatments per 
device/year) to deal with these 154 annual OHCA cardiac arrest cases.  
The reason this paper uses a representative example and not only takes the results from two groups 
in the LINC-study, is that those two sample populations were not equally large (LUCAS n= 1300 and 
manual n= 1289). Having dealt with the size of the cohorts, we can use the fact that there was a 
significant difference in the distribution between the CPC-scores. Also one should remember that the 
results in this analysis would vary if using a different survival and CPC distribution in the cohorts. 
With this hypothetical population and the survival and CPC distribution from the LINC study, Table 5 
shows that out of 154 mechanically OHCA patients, 18.7 (12.2 %) will survive to discharge from ICU 
and of the 154 manually OHCA persons, 18.0 (11.7 %) will survive to ICU discharge. In the LINC-study 
those numbers were 158 out of 1300 in the mechanical group and 151 out of 1289 in the manual 
group, which are the exact same percentages. This calculation example will not only focus on 
patients survival rates but also on their CPC-scores as captured in chapter 4.4. 
TABLE 5 SURVIVAL RATES AND CPC DISTRIBUTION FOR THE COHORTS 
 MECHANICAL CPR (N = 154) MANUAL CPR (N = 154) 
SURVIVAL TO ICU DISCHARGE 18.7 12.2 % 18.0 11.7 % 
WITH CPC 1 6.4 4.2 % 4.1 2.6 % 
WITH CPC 2 5.2 3.4 % 5.7 3.7 % 
WITH CPC 3 4.0 2.6 % 4.8 3.1 % 
WITH CPC 4 3.1 2.0 % 3.5 2.2 % 
SURVIVAL TO HOSPITAL DISCHARGE 13.9 9.0 % 13.9 9.0 % 
WITH CPC 1 10.5 6.8 % 8.0 5.2 % 
WITH CPC 2 2.3 1.5 % 3.9 2.6 % 
WITH CPC 3 1.1 0.7 % 1.8 1.2 % 
WITH CPC 4 0.0 - 0.1 0.1 % 
1- MONTH SURVIVAL 13.3 8.6 % 13.0 8.5 % 
WITH CPC 1 11.6 7.5 % 8.8 5.7 % 
WITH CPC 2 1.5 1.0 % 2.4 1.6 % 
WITH CPC 3 0.8 0.5 % 1.6 1.0 % 
WITH CPC 4 0.0 - 0.1 0.1 % 
6- MONTH SURVIVAL 13.1 8.5 % 12.4 8.1 % 
WITH CPC 1 12.2 7.9 % 10.5 6.8 % 
WITH CPC 2 0.8 0.5 % 1.2 0.8 % 
WITH CPC 3 0.1 0.1 % 0.7 0.5 % 
WITH CPC 4 0.0 - 0.0 - 
 
4.3 Cost estimation 
In the cost estimation the aim in this paper are the costs affecting the health care budget, and the 
cost imposed on society as a whole. Direct costs are machine costs, service costs and additional 
training costs, which will be explored in chapter 4.3.1. Indirect costs occur when patients end up 
producing less than what they did before the cardiac arrest. These costs should be included as they 
are of importance when measuring the value for the society and their possibilities will be explored in 
chapter 4.3.2. 
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4.3.1  Direct Costs 
This analysis will take on the LUCAS device as a yardstick for mechanical CPR. The best estimated 
costs have been calculated from information by people at Physio Control (the owners of the LUCAS 
device) in Lund51.  The sensitivity analysis will present two scenarios where costs are either higher or 
lower, associated with low and high usage. These two scenarios will be used both as sensitivity 
analysis and also to show cost differences when buying a different number of devices. For example 
buying 30 devices could lead to the 15 % lower prices and buying only 8 devices could lead to the 15 
% higher prices. 
 
4.3.1.1 Machine costs, including expendables and maintenance, 
Most costs, except the machine costs, are shared between the two ways of treatment, these are 
therefore excluded from the calculation. However additional training for the paramedics are needed 
and it is assumed that this additional training could be attached to the regular CPR education 
occurring twice a year as stated in the LINC-study. Therefore it is calculated as 2 times 0.5 hours a 
year for each paramedic that uses the LUCAS device52. Data from The Study Protocol for the LINC-has 
been used to calculate the average, low and high usage for LUCAS, see Appendix B. For example the 
number of LUCAS devices that can be used on each battery charger (ranging from 1-20), the number 
of paramedics that will “share” each LUCAS. Lastly LUCAS is a device that does not fit all patients and 
is assumed to be applicable to 95 percent of patients and therefore 95 percent of treatments53. The 
economic lifetime of LUCAS stretches over 8 years and therefore the representative example will 
take on this timeframe for the cost estimation. Together these assumptions give rise to the total 
costs per LUCAS device per year for an 8-year period. The costs are 23,942 SEK per device and year 
ranging from 19,905-31,037 SEK in the two sensitivity scenarios. When applying the 3 percent 
discounting the costs are 22,867 SEK (19,038-29,492SEK) each year for the 8-year period. All costs are 
in 2013 years prices and presented at its full in Appendix M. 
 
4.3.1.2 Variable costs 
In addition to the machine costs there are the treatment costs in form of disposable suction cups 
that will be added on with 285 SEK per treatment. A sole cost that is beyond of the machine and that 
differ between mechanical and manual CPR are the added hospital stay costs. These are calculated as 
depending on the severity of the neurological damage and based on data from LINC-shown in Table 5 
in chapter 4.2. The reason they cost more is that there are more survivors to ICU discharge in the 
group who had been treated mechanically. Surviving patients stay a various amount of time at the 
different hospital services. Data from both ICU discharge and discharge from hospital were available 
to complete this partitioning. In Appendix F, the time in days from ROSC to ICU- and Hospital 
discharge is displayed to tell that most patients stay equally long until being released from the ICU. 
Note that patients with a CPC-score of 4 are in coma and could be removed earlier. The cost per day 
is derived from the cost per minute at the ICU recovery area. Data from Regionvårdsnämnden (2013) 
shows different costs depending on which ICU department patients stay at, see Appendix N. It is 
assumed that the only thing differing between the typical CPC persons is the time spent at the 
recovery room and it is equally likely that patients stay at the two different ICU departments. 
Thereby the cost per day at ICU is calculated to an average of 18,000SEK (15,840-20,160 SEK). With 
this assumption the cost at ICU per average patient is 10,300SEK for a LUCAS treated person and 
9,761SEK for a manually treated person. Remember that less than 12 percent has survived to ICU 
discharge and these are the ones included in the calculation.  
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Appendix F shows that almost all of the patients that at ICU discharge were valued a CPC-score of 4 
have later either improved or more probable died. Since only calculating the costs of those alive this 
means that there is a small sample standing (0.4%). This analysis is assuming that a patient with a 
CPC-score of 4 stays the same amount of days at the hospital as a person with a CPC-score of 3 
(30.13 days). After awakening from the ICU, patients are moved to several different areas in the 
hospital, such as the cardiovascular-, neurology-, internal medicine- and possibly the geriatric 
department (if the patient is aged)54. Since location of patients is not based on the CPC-score, the 
average daily costs of all four departments created a daily cost for each patient of 3,266SEK (2,505-
4,046SEK). With this assumption the cost at the hospital after ICU discharge per average patient is 
4,756SEK for a LUCAS treated person and 4,989SEK for a manually treated person. Together with the 
costs per suction cup these two form the variable costs per patient using the LUCAS device. 
 
4.3.1.3 Presentation of direct costs 
The representative example has 12 devices; each depreciated over 8 years and which will be used on 
95 percent of 154 assumed cardiac arrest cases. Table 6 presents the 2013 future value discounted 
costs in SEK, depending on the number of devices, showing a base-case result of 2,281,601SEK 
(1,913,953-2,917,583SEK). These will late on be depreciated over 8 years. The variable costs are 
calculated from 146.3 treatments (95% of 154 cardiac arrest cases) times the difference in costs per 
average patient in the two groups. The table also shows that the number of devices bought in to deal 
with 154 annual cases do drive costs and will therefor affect ICER results in the analysis. 
TABLE 6  TOTAL DIRECT COSTS, IN SEK 
 15 % Higher and Low 
usage 
Best Estimate 15 % Lower and High 
usage 
Cost per year for LUCAS 29,492 22,867 19,037 
Suction cup costs 41,695 41,695 41,695 
Added Hospital costs 44,630 44,630 44,630 
Total costs 8 devices 1,973,830 1,549,842 1,304,743 
Total costs 12 devices 2,917,583 2,281,601 1,913,952 
Total costs 30 devices 7,164,468 5,574,513 4,655,391 
 
4.3.2 Indirect Costs 
When dealing with the indirect costs of different CPC-values one needs to find out where the 
patients end up after the cardiac arrest and if there are any differences between the CPC groups. This 
paper lacks information about long-term health care costs for survivors or placement depending on 
CPC-score. A sole study to deal after cardiac arrest patients placement by Rittenberger et al. (2011) 
was found not to be applicable to this papers’ population. Their American population consisted of 
half in- hospital cardiac arrests and other half OHCA survivors. Using Kendall’s tau correlation they 
find a poor relationship (0.23) and reason around that CPC is heavily weighted toward mental 
functioning. However their study had a population where 73 percent of the patients had been graded 
a CPC-score of 3 and only 1 percent had a CPC-score of 2. This data does not nearly match the 
Swedish index and it is questioned if their results really could be applied to this study. The Swedish 
National Registry of Cardiac Arrest 201355 shows that around 83 percent has a CPC-score of 1 and 5 
percent has a CPC-score of 3 in the in-hospital cardiac arrest survivors at discharge from hospital in 
Sweden. Further on CPC has been criticized as poorly defined being a subjective measurement56. 
Rittenberger et al. (2011) state that when they were in doubt the focus group would always choose 
the worst outcome, possibly having problems separating CPC group 2 from 3. Also half of their 
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population was in-hospital cardiac arrest survivors whom probably already had some problems that 
might affect the result.  
In the LINC-study the mean age of the patients included was 69.1 years old, proposing that most 
patients were retired at the time of the cardiac arrest. In a study of Swedish cardiac arrest survivors 
from Gothenburg by Graves et al. (1997) the median age was 67 years old (mean= 64 years) and 74 
percent had retired before their arrest. This indicates that possible benefits to society of patients 
returning to work are of less importance. As a calculation of production loss depending on CPC-score 
is very difficult it also brings even more uncertainty into the calculation, whereby it is not included in 
this analysis. Decision-makers do preferably want the societal view in Sweden, but as it the indirect 
costs comes with large uncertainties it is in this paper only debated in chapter 6. This paper will 
instead in chapter 4.4.2 assume that QALYs alone deal with these differences.  
 
4.4 Effects 
This study’s major contribution and difficulty is the measuring of effect. Using the material in 
Appendix C the LINC scores speaks of a small significant difference on the number of patients that 
survive to ICU discharge. This gives the idea that a greater difference exists and by performing an 
illustrative example this study hopes to show just this. In the coming chapters the study will use the 
material in chapter 4.1 to link CPC-scores to QALYs using EQ-5D survey and a focus group. 
 
4.4.1 EQ-5D and the DELPHI method 
The literature gives no direct translation from CPC-scores to a quality of life measure. Instead this 
study turns to a small focus group of five experts in assessing CPC-scores on cardiac arrest patientd. 
The Delphi methode is then used to create a link from CPC to QALYs using a quality of life instrument 
(EQ-5D). It is known that these are two separate instruments used for measuring health on different 
levels and the goal is to find where they overlap and estimate a probable response of how the 
patients, with different CPC-scores, would answer the EQ-5D survey. In Appendix G the reader can 
explore the five dimensions of the EQ-5D survey and the possible response options and there on 
compare it to the CPC description in Appendix A. 
C.-C. Hsu & Sandford (2007) and others have questioned this spur to let experts assess “objective” 
evaluations of the quality of life for patients surviving a cardiac arrest. Yet CPC is a measurement 
used within health care and despite its limitations this study aims to withdraw the effects as far as 
possible. Another possibility would be to let patients judge their own quality of life at these states, 
but this is hard to achieve in the retrospective setting of this paper. It should also be noted that EQ-
5D in itself is a tool for measuring quality of life and it has been observed that the quality of life is 
affected by patients’ own expectations. Methodological problems remains even when patients 
themselves answer the survey57. This study will however assume that the focus group will together 
form the response of a typical person and on average therefore is correct enough to allow 
implementing the results to the cost-effectiveness analysis on an average treated patient. 
                                                                
d
 These experts are the people who assessed CPC-scores of the patients in the LINC-study 
e
 For a more thorough insight to the Delphi-method see “The Delphi Technique: 
Making Sense Of Consensus” by C.-C. Hsu & Sandford (2007) 
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The experts were asked to individually fill in a standard EQ-5D survey on behalf of four typical 
persons each with a separate CPC-score. They had the possibility to not just comment or mark that 
all patients with a specific CPC-score would answer the same way, but also what share of patients 
they believed would answer in a particular way. An example of the survey, in the question of the 
patient mobility, can be seen in Appendix H. 
When the individual surveys were completed, the information were gathered and summed up with 
included comments to subsequently be handed out with the possibility for the experts to revise their 
results. In this way it is believed to seek out information that may generate a consensus on the part 
of the focus group and correlate informed judgments on this topic. The main results from the focus 
group are showed in Appendix I. These are used to the calculation of specific QALY-weights for the 
typical CPC-patients.  
Since no individual data for the patients were available for patients a major assumption was needed 
for the next step. Independence was assumed, when translating the results into QALY-weights, 
between the five dimensions in an EQ-5D survey. This means that a person that has difficulties in one 
dimension will not affect nor be more likely to have problems in another dimension. For example a 
person that is “confined to bed” (level 3 mobility) will not be more likely to have problems in their 
usual activities than a person that has “no problems walking about” (level 1 mobility). This is done to 
be able to calculate the incidence of a constant or any level 3 dimension for the typical “average” 
CPC-person of each score. For example Appendix I show that according to the focus group a CPC-1 
person will 70.8 percent of times have some sort of disability problem, disrupting the 11111 state of 
full health. This typical CPC-1 person will also 20.6 percent of times suffer any level 3 condition, most 
likely stemming from level 3 anxiety or depression. These results could be compared to a typical CPC-
4 person that with these calculations will for certain (100 percent) be affected by both the constant 
and N^3. This is even though none of the level 3 dimensions alone reaches 100 percent.  
EQ-5D was chosen as a result of its simplicity. The limited contact with the experts implies that the 
author has not affected the experts in any improper way. The assumption leads to no variation 
among the patients in each CPC group. Making these results meaningless for improvement efforts 
within the area, but should still be able to function in fulfilling its task in the estimation of costs and 
benefits in this analysis58. The following section will further describe how these translations from 
CPC-scores to EQ-5D gives rise to the QALY-weights. 
 
4.4.2 Health utilities 
Each health condition is associated to a certain QALY-weight that was estimated during a British 
population-study by Dolan (1997). He used the time trade-off method where he asked the 
respondents if they would consider to live on in some amount of years in their current health state 
(for example, frequent migraines) or to live fewer years at full health. Assuming a scenario with 10 
years of migraines, the respondent may be indifferent between this health state and a lifetime of 7 
years at full health. This would mean that each year with the health state frequent migraines is 
associated to a QALY of 0.7. The time trade-off method gives a cardinal value that follows under an 
assumption that choices are made without any risks. Practical issues in the time trade-off method is 
the choice of lifetime and the impact it has on the results. Another available technique is the 
Standard Gamble method that lets patients choose between two alternatives varying the 
probabilities in one of them. The last utility valuation method is the visual analogue scale, which is a 
rating scale based on psychometric theory. It lets the respondent point out the QALY weight on a 
scale where the best and worst possible health states are already attached.  
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Dolan (1997) shows how the deteriorating health gives worsening quality of life values compared to a 
person of full health. According to Drummond et al. (2005) studies have shown that measurements 
of preferences are similar regardless of demographic factors such as nationality, gender and income. 
Therefore the weights can be used to estimate life quality on a Swedish patient population as well. In 
later years Burström et al. (2013) has performed a Swedish experience-based value set for EQ-5D 
health states, using a general population health survey data-set. The Swedish weights will be used as 
a sensitivity analysis for this analysis as they are drawn in a Swedish setting. The reason they do not 
subject under the base-case is that they were created by respondents judging their own health state 
and does not include hypothetical conditions. This could limit their applicability on a CPC-population, 
where CPC 4 patients in a coma would be excluded.  
For a full coefficient-list and QALY-weights see Appendix J. This paper will apply Dolan (1997) original 
approach and not the conservative that limits the QALY-weight to a score between 0-1. It has been 
argued that the vegetative state, associated to a CPC 4 patient is worse than death59. Also since the 
study does not exploit the indirect costs a negative QALY-weight will account for some of this 
shortage. 
 
4.4.3 Calculation of EQ-5D results 
When knowing what coefficients and which to use it is possible to calculate the QALY-weigh for the 
different conditions. For example in Dolan (1997) every theoretical condition is referred to by a 
sequence of digits, where 11111 is the state of full health with a score of 1. The calculation of each of 
the 243 possible conditions starts from the value 1 and subtracts from the score with every 
deviation. Except for the dimensions a constant is subtracted if any dimension reaches level 2 or 3, 
and if any level 3 is reached another harsher constant is added as well. In Appendix K the reader can 
explore a calculation example of the state 11223, which is asserted to a QALY-weight of 0.255 in 
Dolan (1997).  Using the results from the focus group in Appendix I, it is possible to calculate different 
QALY scores for the typical CPC-patient’s condition. Data from Burström & Rehnberg (2006) showed 
in a large study, using Dolans’ conservative approach, that an QALY estimated for an average 65-69 
year old person in Sweden is 0.81. This mean value ranges from 0.71-0.86 depending on which age 
group is observed. This is used to compare to the results obtained from this study where a CPC-1 
patient is referred to a QALY-weight of 0.77, CPC-2 patient; 0.62; CPC-3 patient -0.08; and CPC-4 
patient -0.36. This result strengthen the fact that commonly a CPC score of 1, 2 is considered a good 
outcome and 3, 4 is considered a bad outcome. For a full list of approaches and their QALY-weights 
see Appendix L.  
 
4.4.4 Short-term perspective 
With QALY-weights obtained it is possible to calculate an estimated effect for the hypothetical 
cohorts estimated from the LINC-study. The study starts with the same 6-month perspective as the 
LINC-study and attaches the QALY-weights to the number of days spent in each CPC-state instead of 
using survival as an outcome. This allows us to calculate the estimated QALYs saved per day for the 
entire cohort. This is depending on if the distribution between CPC-scores follow the results of 
mechanical CPR or manual CPR. The short-term effects for the 154 treated cohort shows that 4.58 
QALYs will be saved following the CPC distribution of mechanical CPR and 3.84 QALYs, following the 
CPC distribution of manual CPR. This means that with a time horizon of only the first 6 months after 
the cardiac arrest the cohort is saving 0.74 QALYs if using mechanical CPR instead of manual CPR. 
This means that on average each of the 154 possible treatments would save 0.005 QALYs with this 
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timeframe. The reader should remember that these results would differ if the analysis used another 
distribution than the one taken from the LINC study.  
 
4.4.5 Long-term perspective  
Dramatic changes of CPC between 3 and 12 months after a cardiac arrest are uncommon. Kajaste, & 
Kaste (1993) show that 23 percent of patients have a minor improvement and only 8 percent 
appeared to have worsened in this time period. Drysdale, Grubb, Fox, & O'Caroll (2000) looks at 
memory impairment at 8 months after the cardiac arrest and detects no signs of improvement during 
a three-year follow-up period. In chapter 4.1 we show that Phelps et al. (2013) study will be used to 
link together with data from the LINC-study. In this way we provide the effects up to 8 years (96 
months).  With this base this paper assumes that CPC-values are consistent from 6 months and 
forward. The only thing altering after that is an increased chance of death depending on what CPC-
score the patients had at 6 months. This is applied because no information of patients after 6 months 
was available. 
In Table 7, this paper investigates the linking of the results from Phelps and the LINC-study. This 
created a problem as the LINC-study only had one survivor that was evaluated as a CPC-4 person, 
meaning it is a small sample for long-term outcome. Overall the table shows that people survive at a 
higher degree in the LINC-study and one has to reason around this. It is known that in the LINC-study 
the average amount of days a person stays at the hospital until discharge after a cardiac arrest is 
21.67 days with a median of 17 days. That same number for Phelps study was not available, but 
indications show that a typical patient in America is in for around 7-10 days60. This might also be the 
reason for the higher death rates shown during the first 6 months in Phelps study. The reason that 
patients stay a shorter time in an American hospital might be that they get paid per care event and 
not per hospital day. Also the US patients without health insurances does not have guaranteed 
healthcare that stretches past the acute care.  
TABLE 7 RELATIONSHIP BETWEEN LINC-STUDY AND PHELPS STUDY 
  
Discharge form hospital At 6 months 
  
Number of persons Survivor Number of persons Survivor 
P
h
el
p
s CPC1 606 100 % 572 94 % 
CPC2 227 100 % 190 84 % 
CPC3 97 100 % 70 72 % 
CPC4 50 100 % 17 34 % 
LI
N
C
 CPC1 149 100 % 146 98 % 
CPC2 49 100 % 49 100 % 
CPC3 21 100 % 17 81 % 
CPC4 1 100 % 1 100 % 
 
Since the relationship of survivors seems weak we will use the results from the LINC-study all the way 
up to 6 months. From this point the CPC-distribution will remain the same and start using the survival 
rates from Phelps at 6 months instead of hospital discharge. A new Kaplan-Meier survival rates 
starting at 6 months was created in Excel and can be seen in  
 
Appendix E. When comparing the two survival graphs in the appendix, one can see that some of the 
former clear relationship between survival and CPC-score has been lost. However, after 6 months 
people with a CPC of 1 or 2 is still dying in a slower pace than those with a CPC of 3 or 4. This result 
strengthen the fact that commonly a CPC-score of 1, 2 is considered a good outcome and 3, 4 is 
considered a bad outcome. 
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4.4.6 Presentation of effects 
Figure 6 shows the QALYs saved for the cohorts in each month, based on the short-term and the 
long-term calculations. The space between the two lines is the gained QALYs for mechanical CPR 
compared to manual CPR. The graph shows non-discounted effects. The first 6 months has been 
calculated so that the QALYs gained during ICU stay, hospital stay and up to one month occurs in 
month 1. The gained effects made during month two to six has been divided by five and that is why 
they are linear at this point in time. The graph also indicates that effects do keep adding up when 
looking at a longer time horizon. This might be of value for decision-makers that not only look at 
survival, but also instead want the analysis with a longer time horizon.   
FIGURE 6 SAVED QALYS PER MONTH, PER COHORT 
 
 
As the aggregated effects do get larger with time, the uncertainty in the result is also increasing. The 
8 year discounted effects of being treated with mechanical CPR gives 7.14 (5.96-6.94) QALYs gained 
for the 154 person cohort. This implies that for each treated OHCA patient on average 0.046 (0.039-
0.045) QALYs will be saved during this timeframe, remembering that only approx. 13 treated patients 
per group survived up to 6 months. The numbers in the brackets are calculated with the Swedish and 
conservative approach.  
This is the first calculation of its kind and it shows that the largest gains in QALYs saved per month for 
mechanical CPR is being made during the period from 1-6 months after ROSC. This is mainly because 
more patients in the treated cohort are alive during this time.  
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5. Results 
In this chapter, the base-case analysis results for a short-term (6 months) and long-term (8 years) 
along with sensitivity scenarios will be presented. The costs will be presented from a health care 
budget perspective. 
 
5.1 Base-case analysis 
The result is presented in terms of direct cost only. The cost estimation for the representative 
example of a pre-hospital area with 154 cardiac arrest cases a year and 8 LUCAS devices shows the 
following results in Table 8, in SEK (2013). The results should be viewed as additional costs for the 
mechanical device. The table refers to the hospital stay costs as an extra cost for mechanical CPR 
compared to manual CPR, inferring that manual CPR is not free of charge. 
With the assumptions explained in chapter 4 the results indicate that in a short-term (6 months) 
mechanical CPR is associated with 508,291 SEK per QALY gained. In Table 2 this is referred to as a 
“high” cost per QALY gained. The vague thresholds created for the cost-effectiveness principle say 
that these costs need to fall below 500,000 SEK per QALY gained to be considered as moderate costs. 
When stretching the timeframe up to 8 years after the cardiac arrest, the result of the analysis shows 
that the cost is 50,508 SEK per QALY gained, indicating a “low” cost. The costs differ between the two 
columns because in the long-term the costs are discounted at 3 percent.  
The reason the results differ so much between the two time horizons are that the costs for treating 
patients with a mechanical device are the same no matter how long after treatment the decision-
maker believes to stretch his timeframe. If for example one would only look at survival at a certain 
point then there would be no difference in effects and you could take on the cost-minimizing 
analysis. Then mechanical CPR would be far more expensive than manual CPR and we could conclude 
that mechanical CPR is dominated by manual CPR. When instead extracting the time horizon to 6-
months and using CPC-scores to calculate QALYs, the effects come at a “high” ICER cost. In this paper 
we have also extracted the effects beyond the typical 6 months or 1 year to the same period as an 
economic lifetime of the mechanical device. In this way the decision-maker can see effects further 
down the line from the costs they invested in the mechanical devices. This implies that the money 
invested is more cost-effective than what could be believed from viewing only survival as an 
outcome.  
 
TABLE 8 COST-EFFECTIVENESS FOR MECHANICAL CPR VS. MANUAL CPR IN A OHCA SETTING (2013 SEK) 
 Short-term (6 months) Long-term (8 years) 
 Costs QALYs Costs QALYs 
Mechanical 373,626 4.58 360,736 59.90 
       Machine 287,300  274,409  
       Treatment 41,696  41,696  
       Extra Hospital stay 44,631  44,631  
Manual  3.84  52.76 
Difference 373,626 0.74 360,736 7.14 
ICER, SEK 508,291  50,508  
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5.2 Sensitivity Scenarios 
The results of the base-case analysis are based on the assumptions that have been accounted for in 
the previous chapter 4. Different sensitivity scenarios were performed to test the impact on the main 
result. In Table 9 the sensitivity analysis of one variable at a time is presented. Revealing that the 
driving factors in result stems from the time horizon of the effects and the number of devices needed 
to treat the cohort. Other scenarios checked are which QALY-calculation approach to use, which 
discounting percentages or if we want to change the costs at ICU and hospital stay. The thesis aims at 
applying a Swedish setting and by using the Burström weights we obtain a higher ICER cost for 
mechanical CPR. This is based on the knowledge that over the 8-year discounted period the 
mechanical device saves 5.963 QALYs compared to saving 7.142 using Dolans calculations. One 
possible way to implement these Swedish weights with more ease would be to assume the same 
quality of life for a person with CPC-score of 4 and one with a score of 3. In this case we could use the 
Swedish weights, even though they are not created to include hypothetical conditions (CPC-score of 
4).  Keeping the same QALY-approach throughout the analysis timeline is more practical and serves 
easier for translating the results to other non-Swedish populations.  
Using a 5 percent discounting rate to both costs and effects adds 2,471 SEK to the cost per gained 
QALY. If disregarding discounting we can subtract 2,789 SEK. If we had used the newer QALY-weights 
with a Swedish approach, then effects between the two treatment groups would be smaller than 
presented. The cost per gained QALY would be 9,985 SEK higher and even more when looking with a 
short-term time horizon.  
 
TABLE 9 UNIVARIATE SENSITIVITY ANALYSIS 
Parameter Total benefit Total Annual Costs (SEK) ICER (SEK) 
Baseline 7.142 360,736 50,508 
Discount rate    
  0 percent 7.830 373,626 47,719 
  5 percent 6.744 357,298 52,979 
Number of devices    
  8 devices (19.25 treatments/device) 7.142 269,266 37,701 
  30 devices (5.13 treatments/device) 7.142 772,350 108,141 
Machine costs    
  -15 percent & high usage 7.142 314,780 44,074 
  +15 percent & low usage 7.142 440,233 61,639 
Time horizon    
  5 years 5.010 360,736 72,006 
  1 year 1.287 373,626 290,402 
  6 months 0.735 373,626 508,291 
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QALY-calculation    
  Conservative approach 6.937 360,736 52,000 
  Swedish approach 5.963 360,736 60,493 
Hospital stay    
  Cost per day 2,502 7.142 368,739 51,629 
  Cost per day 4,046 7.142 352,574 49,366 
  Added cost per ICU stay 15,840 7.142 351,276 49,184 
  Added cost per ICU stay 20,160 7.142 370,195 51,833 
 
Some multivariate sensitivity analysis should also be of value for the decision-maker. If for example 
believing that the pre-hospital region do not take on 12.83 treatments per year, they are here 
presented with cases where more or less devices are supplied for the annual OHCA cases. If believing 
that each device can be expected to deal with as many as 19.25 treatments per year they might buy 
8 devices at 15 % higher costs. This would lead to a cost per QALY gained of 45,122 SEK in the 8 year 
timeframe and 455,225 SEK per QALY gained with a 6 months’ timeframe. If the decision-maker 
instead believes that each device will be applied to fewer treatments each year (5.13) they will in the 
case of this representative example buy 30 devices and we could also assume 15 % lower costs. This 
would lead to a cost per QALY gained of 92,054 SEK in the 8-year timeframe and 929,807 SEK per 
QALY gained with a 6 months’ timeframe, varying plenty from baseline results. 
The baseline results stems from a case where a region has 128 OHCA cases and 12 mechanical 
devices. The numbers of devices are based on Appendix B that shows for example that Uppsala had 
50 OHCA cases and 10 devices, meaning 5.00 treatments per device. The decision-maker for Uppsala 
would then be better of looking at the cost per QALY gained for the case of 30 devices per 154 OHCA 
cases (5.13 treatments per device) than the baseline results (12.83 treatments per device). 
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6. Discussion 
The purpose of this paper has been to perform a cost-effectiveness analysis to explore the cost-
effectiveness of mechanical CPR compared to manual CPR. This is a current topic as a recent large 
randomized controlled trial has been published in the LINC-study. Studies have shown that there 
does not exist any change in survival between treatments. This paper has with the help of the 
neurological outcomes in the LINC-study tried to show that some difference in quality-adjusted life 
years are there to be exploited. It should be remembered that given another survival distribution 
results from the calculations would be altered.  
This paper presented a typical representative example of SUS, Malmö pre-hospital region where 12 
devices deals with 154 OHCA cases. The results in this paper hope to help the decision-maker when 
evaluating whether to purchase mechanical devices for treatment of OHCA patients. The paper hope 
to show that survival is not the only effect-measurement available and that the benefits of 
mechanical CPR add up with a longer timeframe. The main result with an 8-year timeframe for 
effects, indicate that when comparing mechanical CPR to manual CPR the costs per QALY gained are 
considered as “low”, according to The Swedish National board of Health and Welfare. If instead only 
applying the 6-months results from the LINC-study the costs per QALY gained are “high" according to. 
The results indicate that both the number of treatments per device and year and the timeframe used 
to measure effects do drive the costs and effect a great deal. Implying that decision-maker need to 
perceive the number of possible treatments the devices when thinking about buying mechanical 
devices.  
This study does display that CPC-scores are not an optimal outcome measurement and have its share 
of critique. However this study does fully explore the CPC-scale and tries to withdraw all information 
available to give meaning to the results. Much of this analysis builds on the assumption that the 
focus group is able to derive the CPC-score into possible EQ-5D answers. The Delphi method is used 
by the Swedish national board of health and welfare (Socialstyrelsen) as to make consensus in 
difficult decisions within health care guidelines. Possible weakness to the method could be that the 
experts did not put enough time and effort into the survey. Also a consensus among expert does not 
necessarily mean it is the correct prediction. Also these are predictions the experts are assessing and 
those almost always come with uncertainty. Another limitation is the assumption of independence 
among the different dimensions in EQ-5D. Otherwise the calculation of the constant and N^3 would 
not be possible at an aggregated level. In chapter 4.4.1 we talk about added levels to the dimension 
but not added dimensions in the Health Related Quality of Life-instrument. The last limitation is that 
we cannot for natural reasons differ between survivors and non-survivors in terms of extra hospital 
stay costs. We do instead calculate the cost per average OHCA patient depending on if they were 
treated with mechanical CPR or manual CPR.  
The results in this paper also suffer from not obtaining any CPC varying costs to society for the 
patients after their hospital stay. Decision-makers should regard the effects of these limitations when 
setting priorities. In this paragraph we discuss the usage of mechanical CPR in a societal view. 
Mechanical CPR could possibly effect in more ways than those that have been explored in this 
analysis. Several studies identify that usage of seatbelt will halve the risk of injury or death at a 
possible crash during transport61. Slattery & Silver (2009) acknowledge the possible strategies for 
mitigating the risks by for example improving ambulance safety standards or freeing up providers’ 
hands by the availability of e.g. mechanical CPR devices. If assuming that mechanical CPR lets the 
paramedics be seated in the back during emergency calls L. Becker (2003) demonstrated that 
compared to being unrestrained the passengers were less likely to suffer from fatal-, severe- and 
moderate- injuries. This indicate to the possibility of mechanical CPR having even lower costs per 
33 
 
QALY gained for the society and it makes rise for a CEA study of mechanical CPRs during emergency 
ambulance ride. 
Jones & Lee (2005) indicated through a questionnaire in Hong Kong that back pain in ambulance 
officers could be linked to CPR as it is often undertaken in compromised positions. There are, 
however, no reports of any relationship between CPR and the prevalence of back pain in ambulance 
officers. Still this is an area worth exploring for future studies that want to compare the utility gains 
for mechanical CPR. 
Blomqvist, Mattson, & Hellström-Hyson (2012) performed a small qualitative study at pre-hospital 
CPR where they examined how a mechanical CPR system has affected paramedics working 
environment. Opinions on mechanical CPR impact were unanimously positive as it lowered stress, 
increased safety during transport and provided better contact with patients. They also emphasized 
the usage of mechanical CPR as a tool only and that the skill of regular manual CPR still needs to be 
applied on patients that do not fit and in case the mechanical device abruptly stops working.  
Axelsson (2008) shares the experiences from mechanical CPR at OHCA, in the Gothenburg area. The 
report strengthens the former reports but also speaks of some deviations during the study period. 
Experiences such as a blister on the body from the suction cup sliding, complaints about that the 
equipment being too big and heavy to be included in the standard equipment. They spoke of the 
occurrence of rib fractures on patients, which is a phenomenon that has been better documented in 
a book by Smekal (2013). His studies have shown that any rib fracture is 14-15 percent more likely to 
appear from mechanical CPR than from manual CPR. These effects, from using mechanical CPR 
compared to manual CPR, are likely to affect the QALY gained negatively among survivors. 
Possible future research could be following up OHCA patients with a longer timeframe to see where 
they end up after their discharge from hospital. This research would hopefully divide results by both 
age groups and CPC-scores. Other possibilities are also to use a more exploring measurement than 
the CPC-scale and maybe let patients themselves answer a Health Related Quality of Life-instruments 
as soon as they are able.  
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7. Conclusion  
This thesis aims at giving a value for decision-makers when comparing mechanical CPR vs. manual 
CPR in OHCA, in Sweden. It includes a mapping of CPC-scores to QALY-weights and calculates a short- 
and long-term utility for mechanical CPR. This study believes to have given a transparent overview of 
a representative example facing decision-makers. Leaving them with the possibility to look at the 
value of mechanical CPR over a longer period and not just in the short run and with survival as the 
only outcome. The study concludes that if decision-makers are willing to live with uncertainties 
discussed and argued in this paper, then mechanical devices are available at “low” costs per QALY 
gained for the patients treated timeframe. On top of this, the author believes that mechanical device 
should be viewed as a tool to be more valuable the longer it is expected to function. The study states 
that this 8-year timeframe is a suitable time-horizon for decision-makers to calculate the effects as 
this is the economic lifetime for a LUCAS device and that surviving patients are expected to live on 
after a cardiac arrest even though an OHCA population has a mean age in the older 60s.  
When looking at patient utilities in the QALY-weights obtained from CPC-scores. The paper concludes 
that recent research in the area is correct to divide neurological outcomes in good (CPC 1,2) and bad 
(CPC 3,4) outcomes instead of using the whole scale. The QALY-weights obtained from results by the 
focus group should not be used in medical evaluation but could still work as an indicator of economic 
results. Future research should look to see where patients end up based on the CPC-scores, to be 
able to more accurately evaluate long-term costs and effects of mechanical CPR and manual CPR. 
This study does however believe to have done the best with the research available.  
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Cerebral Performance Category Scale
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 CPC 1 - Good cerebral performance: conscious, alert, able to work, might have mild neurologic or 
psychological deficit. 
 CPC 2 - Moderate cerebral disability: conscious, sufficient cerebral function for independent activities 
of daily life. Able to work in sheltered environment. 
 CPC 3 - Severe cerebral disability: conscious, dependent on others for daily support because of 
impaired brain function. Ranges from ambulatory state to severe dementia or paralysis.  
 CPC 4 - Coma or vegetative state: any degree of coma without the presence of all brain death criteria. 
Unawareness, even if appears awake (vegetative state) without interaction with environment; may 
have spontaneous eye opening and sleep/awake cycles. Cerebral unresponsiveness. 
 CPC 5 - Brain death: apnea, areflexia, EEG silence, etc 
 
Appendix B  
The Study Protocol for the LINC
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City Nr. 
Hospitals 
Nr. 
Paramedics 
Treatments 
/ year 
Nr. 
Lucas 
Treatments 
/ LUCAS 
Paramedics 
/ LUCAS 
Uppsala 1 85 50 10 5.00 8.50 
Gävle 1 106 55 9 6.11 11.78 
Västerås 1 55 55 8 6.88 6.88 
Malmö 1 150 140 12 11.67 12.50 
Dorset 2 100 135 26 5.19 3.85 
Utrecht 8 275 225 50 4.50 5.50 
Average 2.33 128.50 110 19.17 5.74 6.70 
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Appendix C 
LINC CPC-scores
64
 
 
The p-value presented to the far right is the probability of obtaining the observed sample results (or 
a more extreme result) when the null hypothesis (LUCAS saving more people to a CPC specific CPC-
score) is actually true. The significance level is traditionally set to 5 or 1 percent, but could with lower 
presumption against the hypothesis be moved to a 10 percent level. 
 
Appendix D  
Kaplan-Meier estimates: Survival with start at discharge from hospital 
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Appendix E  
Kaplan-Meier estimates: Survival with start at 6 months 
 
 
Appendix F  
Time in days from ROSC to ICU/Hospital discharge
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CPC at ICU discharge N ( %) Median (Q1-Q3) Range Mean (SD) 
CPC 1 87 (28.2 %) 4.0 (1-7) 0-30 5.18 (5.5) 
CPC 2 92 (29.9 %) 4.0 (2-7) 0-27 5.14 (4.9) 
CPC 3 74 (24.0 %) 4.0 (1-7) 0-25 5.15 (5.4) 
CPC 4 55 (17.9 %) 1.0 (0-3) 0-14 2.42 (3.4) 
Total 308 (100 %) 3.0 (1-6) 0-30 4.67 (5.1) 
     
CPC at Hospital discharge     
CPC 1 155 (66.8 %) 17.0 (11-28) 0-106 20.37 (14.1) 
CPC 2 52 (22.4 %) 17.5 (11-31) 0-61 21.77 (14.7) 
CPC 3 24 (10.3 %) 25.5 (12-47) 0-84 30.13 (22.7) 
CPC 4 1 (0.4 %) 14.0 (14-14) 14-14 14.00 () 
Total 232 (100 %) 17.0 (11-29) 0-106 21.67 15.5) 
 
Appendix G  
Dimensions in EQ-5D
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Mobility 
1. No problems walking about 
2. Some problems walking about 
3. Confined to bed 
Self-Care 
1. No problems with self-care 
2. Some problems washing or dressing self 
3. Unable to wash or dress self 
Usual Activities (e.g. work, study, housework, family or leisure activities) 
1. No problems with performing usual activities  
2. Some problems with performing usual activities 
3. Unable to perform usual activities 
0,10
0,20
0,30
0,40
0,50
0,60
0,70
0,80
0,90
1,00
6 9
1
2
1
5
1
8
2
1
2
4
2
7
3
0
3
3
3
6
3
9
4
2
4
5
4
8
5
1
5
4
5
7
6
0
6
3
6
6
6
9
7
2
7
5
7
8
8
1
8
4
8
7
9
0
9
3
9
6
MONTHS 
CPC1 CPC2 CPC3 CPC4
38 
 
Pain/Discomfort 
              1. No pain or discomfort 
2. Moderate pain or discomfort 
3. Extreme pain or discomfort 
Anxiety/Depression 
1. Not anxious or depressed 
2. Moderately anxious or depressed 
3. Extremely anxious or depressed 
 
Appendix H  
Example of EQ-5D survey 
 
 
Appendix I  
Results from Focus-group 
 Dimension CPC 1 CPC 2 CPC 3 CPC 4 
Mobility level 1 91.0 % 64.0 % 18.0 % 0.0 % 
Mobility level 2 9.0 % 34.0 % 38.0 % 2.0 % 
Mobility level 3 0.0 % 2.0 % 44.0 % 98.0 % 
Self-care level 1 94.0 % 74.0 % 6.0 % 1.0 % 
Self-care level 2 6.0 % 26.0 % 32.0 % 4.0 % 
Self-care level 3 0.0 % 0.0 % 62.0 % 95.0 % 
Usual-activity level 1 93.0 % 76.0 % 3.0 % 1.0 % 
Usual-activity level 2 7.0 % 21.0 % 10.0 % 1.0 % 
Usual-activity level 3 0.0 % 3.0 % 87.0 % 98.0 % 
Pain/Discomfort level 1 72.0 % 61.0 % 35.7 % 34.0 % 
Pain/Discomfort level 2 26.0 % 28.0 % 30.7 % 24.0 % 
Pain/Discomfort level 3 2.0 % 11.0 % 33.7 % 42.0 % 
Anxiety/Depression level 1 51.0 % 45.0 % 16.0 % 2.5 % 
Anxiety/Depression level 2 30.0 % 34.0 % 30.0 % 13.8 % 
Anxiety/Depression level 3 19.0 % 21.0 % 54.0 % 83.8 % 
Constant 70.8 % 90.1 % 100.0 % 100.0 % 
N^3 20.6 % 33.2 % 99.2 % 100.0 % 
N^3 = if any dimension has a level 3 score  
 
 
Appendix J  
Dolan and Burström Coefficients
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What is the probability that an average person with a value of 2 on CPC scale answers: 
 
 No problems walking about   __________% 
 
 Some problems walking about   __________% 
 
 Confined to bed    __________% 
 
Additional Comments: _______________________________________________________ 
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  Dolan (1997) Burström et al. (2013) 
Dependent Variable 1-TTO TTO 
Intercept 0.081 0.969 
Mobility   
      Level 2 0.069 -0.067 
      Level 3  0.314 -0.125 
Self-care   
      Level 2 0.104  
      Level 3 0.214  
      Level 2 or 3  -0.028 
Usual Activities   
     Level 2 0.036 -0.101 
     Level 3 0.094 -0.136 
Pain/Discomfort   
     Level 2 0.123 -0.035 
     Level 3 0.386 -0.090 
Anxiety/Depression   
     Level 2 0.071 -0.055 
     Level 3 0.236 -0.208 
N3^ 0.269 -0.043 
N^3 = If any dimension has a level 3 score 
 
Appendix K  
Calculation example of state 11223 
Full health 1.000 
Constant term (for any dysfunctional state) -0.081 
Mobility: level 1 0.000 
Self-care: level 1 0.000 
Usual activities: level 2 -0.036 
Pain or discomfort: level 2 -0.123 
Anxiety or depression: level 3 -0.236 
Level 3 occurs within at least one dimension -0.269 
Therefore, the estimated value for 11223 = 0.255 
 N^3 = If any dimension has a level 3 score 
Appendix L  
QALY-weights  
Approach to calculation CPC 1 CPC 2 CPC 3 CPC 4 
Dolan Conservative 0.77 0.62 0.00 0.00 
Dolan Original 0.77 0.62 -0.08 -0.36 
Swedish Weights 0.88 0.81 0.52 0.41 
     
 
 
 
 
Appendix M 
Cost table 
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Appendix N 
Costs for hospital stay  
15 % Higher and Low usage Best Estimate 15 % Lower and High usage
Machine cost 108 100 kr 94 000 kr 79 900 kr
Machine life years 8 8 8
Machine costs per year 13 513 kr 11 750 kr 9 988 kr
Power supply 3 450 kr 3 000 kr 2 550 kr
Power supply life years 8 8 8
Total power supply costs per year 431 kr 375 kr 319 kr
Battery charger 8 855 kr 7 700 kr 6 545 kr
Battery charger life years 8 8 8
Number of LUCAS per Battery charger 20,00 12,00 8
Total battery charger costs per LUCAS per year 55 kr 80 kr 102 kr
Average Battery cost (no discount) 6 900 kr 6 000 kr 5 100 kr
Average Battery cost (8 years) discounted 3% 6 331 kr 5 505 kr 4 679 kr
Average Battery cost (8 years) discounted 5% 6 003 kr 5 220 kr 4 437 kr
Battery life years 3 3 3
Number of batteries needed 3 2 2
Total battery costs per year (no discounting) 6 900 kr 4 000 kr 3 400 kr
Total battery costs per year (discounted 5% 3%) 6 331 kr 3 670 kr 3 120 kr
Total battery costs per year (discounted 5% 5%) 6 003 kr 3 480 kr 2 958 kr
Service cost per year (no discounting) 6 900 kr 6 000 kr 5 100 kr
Service cost per year (8 years) discounted 3% 6 236 kr 5 423 kr 4 609 kr
Service cost per year (8 years) discounted 5% 5 853 kr 5 090 kr 4 326 kr
Average Training costs for 1 paramedic 1h a year (no discount) 259 kr 259 kr 259 kr
Average Training costs for 1 paramedic 1h a year (8 years) discounted 3% 234 kr 234 kr 234 kr
Average Training costs for 1 paramedic 1h a year (8 years) discounted 5% 220 kr 220 kr 220 kr
Number of parademics on each LUCAS 12,50 6,70 3,85
Training costs per year (1 year/no discount) 3 238 kr 1 736 kr 996 kr
Training costs per year (discounted 3%) 2 926 kr 1 569 kr 900 kr
Training costs per year (discounted 5%) 2 746 kr 1 473 kr 845 kr
Total cost for LUCAS per year (no discounting) 31 037 kr 23 942 kr 19 905 kr
Total cost for LUCAS per year (discounted 3%) 29 492 kr 22 867 kr 19 038 kr
Total cost for LUCAS per year (discounted 5%) 28 985 kr 22 581 kr 18 821 kr
Suction Cup price per treatment 285 kr 285 kr 285 kr
Number of OHCA-treatments for LUCAS per year 146,3 146,3 146,3
Total Suction Cup costs per year 41 696 kr 41 696 kr 41 696 kr
Extra Hospital Costs per OHCA patient 305 kr 305 kr 305 kr
Number of OHCA-treatments for LUCAS per year 146,3 146,3 146,3
Total Hospital costs per year for cohort 44 631 kr 44 631 kr 44 631 kr
Total 8 years cost for 30 LUCAS devices (no discounting) 1 017 424 kr 804 575 kr 683 466 kr
Total 8 years cost for 30 LUCAS devices (discounted 3%) 971 094 kr 772 350 kr 657 460 kr
Total 8 years cost for 30 LUCAS devices (discounted 5%) 955 867 kr 763 756 kr 650 954 kr
Total 8 years cost for 8 LUCAS devices (no discounting) 334 619 kr 277 859 kr 245 564 kr
Total 8 years cost for 8 LUCAS devices (discounted 3%) 322 264 kr 269 266 kr 238 629 kr
Total 8 years cost for 8 LUCAS devices (discounted 5%) 318 204 kr 266 974 kr 236 894 kr
Total 8 years cost for 12 LUCAS devices (no discounting) 458 765 kr 373 626 kr 325 182 kr
Total 8 years cost for 12 LUCAS devices (discounted 3%) 440 233 kr 360 736 kr 314 780 kr
Total 8 years cost for 12 LUCAS devices (discounted 5%) 434 143 kr 357 298 kr 312 177 kr
41 
 
Department  Daily costs 
Cardiovascular 2,983 SEK 
Hospital days, normal fee 2,983 SEK 
Neurology and rehabilitation medicine  3,535 SEK 
Hospital days, normal fee 3,584 SEK 
Nursing day 3,520 SEK 
Hospital days, normal fee, inpal pat 3,500 SEK 
Internal medicine 2,505 SEK 
Hospital days, normal fee 2,502 SEK 
Geriatric 4,046 SEK 
Nursing day 4,021 SEK 
Hospital days, normal fee, inpal pat 4,071 SEK 
Average cost per day 3,266 SEK 
  
  
Cost per day (ICU) 18,000 SEK 
Popmin 15,840 SEK 
Vårdmin 20,160 SEK 
 
42 
 
 
                                                                
1
 (Rubertsson et al., 2013) 
2
 (" ationella riktlinjer f r hj rtsjukv rd - ilaga 3 till beslutsst dsdokument – Metod," 2008) 
3
 (Rubertsson et al., 2013) 
4
 (Herlitz, 2013; "Socialstyrelsen.se," 2014). 
5
 (Eftestøl, Sunde, & Steen, 2002;105(9); Paradis, Martin, Rivers, & al., 1990;263(8); Sato, Weill, Sun, & al., 
1997;25(5); Steen, Liao, Pierre, Paskevicius, & Sjöberg, 2002;55(3)) 
6
 (Herlitz, 2013; Nolan, Deakin, Soar, Böttiger, & Smith, 2005) 
7
 (Rubertsson, Grenvik, Zemgulis, & Wiklund, 1995;23(12)) 
8
 (Olasweengen, Wik, & Steen, 2008;76(2); Wik et al., 2005) 
9
 (Westfall, Krantz, Mullin, & Kaufman, 2013; 41(7)) 
10
 (Rubertsson et al., 2013) 
11
 (Perkins, Woollard, Cooke, Deakin, & al., 2010; Tenhunen et al., 2014) 
12
 ("Läkemedelsförmånsnämndens allmäna råd," 2003) 
13
 (Drummond, Sculpher, Torrance, O'Brien, & Stoddart, 2005) 
14
 (Jönsson, 1999) 
15
 (Drummond et al., 2005) 
16
 (Drummond et al., 2005) 
17
 (Drummond et al., 2005) 
18
 TLV, is a central government agency whose remit is to determine whether a pharmaceutical product or 
dental care procedure shall be subsidized by the state. We also contribute to quality service and accessibility of 
pharmacies. 
19
 ("Läkemedelsförmånsnämndens allmäna råd," 2003) 
20
 (Drummond et al., 2005) 
21
 (Drummond et al., 2005) 
22
 (Drummond et al., 2005) 
23
 (Bernfort, 2012) 
24
 (Drummond et al., 2005) 
25
 (" ationella riktlinjer f r hj rtsjukv rd - ilaga 3 till beslutsst dsdokument – Metod," 2008) 
26
 (" ationella riktlinjer f r hj rtsjukv rd - ilaga 3 till beslutsst dsdokument – Metod," 2008) 
27
 (Torgerson & Raftery, 1999) 
28
 ("Läkemedelsförmånsnämndens allmäna råd," 2003) 
29
 (Kobelt, 2002) 
30
 (Herlit ,    3; "Pl tslig hj rtd d, en temaskrift fr n Hj rt-Lungfonden, 2006," 2006) 
31
 (Eftestøl et al., 2002;105(9); Paradis et al., 1990;263(8); Sato et al., 1997;25(5); Steen et al., 2002;55(3)) 
(Herlitz, 2013; Nolan et al., 2005) 
32
 (Rubertsson et al., 1995;23(12)) 
33
 (Olasweengen et al., 2008;76(2); Wik et al., 2005) 
34
 (Association, 2010) 
35
 (Steen, Liao, Pierre, Paskevicius, & Sjöberg, 2003;58(2)) 
36
 (Corporation) 
37
 (Herlit ,    3; "Pl tslig hj rtd d, en temaskrift fr n Hj rt-Lungfonden, 2006," 2006) 
38
 (Cummins RO et al., 1991) 
39
 (Jennett B & M, 1975) 
40
 (Herlitz, 2013) 
41
 (Andersson et al., 2011) 
42
 (L. B. Becker, Aufderheide, & al., 2011) 
43
 (J. W. Hsu, Madsen, & Callaham, 1996; Rittenberger, Raina, Holm, Joo Kim, & Callaway, 2011;82; Stiell et al., 
2009;53) 
44
 ("HLR.nu," 2012) 
45
 (Engdahl, Bång, Lindqvist, & Herlitz, 2003; Graves et al., 1997) 
46
 The paper present one more animal study not included in the table. 
47
 (Olsson & Steen, 2008) 
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48
 (Rubertsson et al., 2013;21:5) 
49
 (Bernfort, 2009) 
50
 (Cummins RO et al., 1991) 
51
 (Arnwald, Lindroth, & von Schenck, 2014) 
52
 (Ekonomifakta, 2014; SCB, 2014) 
53
 (Rubertsson et al., 2013) 
54
 (Smekal, 2014) 
55
 (Herlitz, 2013) p. 57 
56
 (J. W. Hsu et al., 1996) 
57
 (Carr & Higginson, 2001) 
58
 (Ranstam, Robertsson, W-Dahl, Löfvendahl, & Lidgren, 2011) 
59
 (Patrick, Starks, Cain, Uhlmann, & Pearlman, 1994) 
60
 (Mayo,    4; O’Riordan,     ; Villegas,    4) 
61
 (L. Becker, 2003; Petzäll, 2008; Slattery & Silver, 2009) 
62
 (L. B. Becker et al., 2011;124) 
63
 (Rubertsson et al., 2013;21:5) 
64
 (Rubertsson et al., 2013) 
65
 (Rubertsson et al., 2013) 
66
 (Dolan, 1997) 
67
 (K Burström et al., 2013; Dolan, 1997) 
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